Sam focuses his practice on healthcare regulatory compliance, general corporate representation of healthcare providers and suppliers, contract negotiation, and transactional matters.
The mainstay of his practice is providing guidance to medical device companies regarding FDA approval pathways, fraud and abuse issues, off-label promotion, adverse event reporting, negotiating clinical trial agreements, negotiating and structuring discount and rebate agreements, developing and implementing compliance programs, and other regulatory and compliance matters. His experience includes developing and negotiating royalty and consulting arrangements, addressing intellectual property issues, and handling a variety of commercial matters for device companies.
Sam also represents a wide range of healthcare providers and suppliers in regulatory matters relating to fraud and abuse laws, including anti-kickback laws, the Stark Law, Medicare coverage and reimbursement rules, and state healthcare laws and regulations. He regularly assists healthcare providers and suppliers in responding to government investigations, addressing compliance concerns, and responding to and appealing prepayment and post-payment audits by government contractors and commercial payors.
In addition, Sam routinely provides guidance to laboratories on matters such as sales and marketing regulatory compliance, order documentation requirements, reference laboratory issues, and fraud and abuse compliance. Sam also frequently advises laboratories regarding joint ventures and other affiliations with healthcare providers.
Sam also regularly provides regulatory advice regarding and manages transactional matters, including public and private offerings, mergers and acquisitions, and joint ventures. Sam formerly held Series 6, 63, and 26 securities licenses, was an Illinois licensed insurance producer and mortgage broker, and is an Illinois licensed real estate broker.
Sam is also a regular speaker at industry conferences and corporate seminars.
Experience
- Advised medical device manufacturer regarding off-label concerns, including the need to pursue a 510(k) in light of alleged safety and efficacy issues.
- Advised digital health company regarding FDA device exemptions under the 21st Century Cures Act.
- Negotiated industry-sponsored and investigator-initiated trial agreements for device companies.
- Assisted pharmaceutical company with obtaining HCPCS code for a drug.
- Counseled medical device manufacturer regarding FDA Mandatory Medical Device Reporting Requirements.
- Developed code of conduct and compliance policies for mid-size medical device manufacturer.
- Negotiated royalty and consulting agreements for a medical device manufacturer.
- Developed discount and rebate programs for medical device manufacturers.
- Provided compliance advice regarding outcomes-based (and value-added) sales models.
- Advised a durable medical equipment supplier regarding compliance with Medicare supplier standards.
- Resolved multi-million dollar commercial overpayment dispute for a laboratory.
- Conducted comprehensive compliance review of a clinical laboratory.
- Conducted comprehensive compliance reviews of dialysis chain providers.
- Completed private placement for an early-stage medical device manufacturer.
- Advised specialty hospital chain regarding fraud and abuse compliance.
- Counseled providers and suppliers regarding satisfying Medicare conditions of payment, conditions of participation, conditions of coverage, and enrollment requirements.
- Represented physicians and other licensed professionals regarding complying with advertising and professional conduct restrictions.
- Facilitated $487 million dollar public offering for an insurance company.
- Represented a multistate physician practice in its $61.1 million dollar sale to a private equity firm.
- Represented a private equity firm in providing a $75 million dollar senior secured credit facility to a multistate physician practice.
- Represented a private equity firm in a $2.5 million dollar investment in a dental practice.
- Represented multiple nephrology practices in establishing dialysis facility joint ventures.
- Developed and negotiated residency affiliation agreements for a medical school with training sites and hospitals.
-
University of Illinois College of LawJD
magna cum laude, Order of the Coif
2008 - University of Illinois at Urbana-ChampaignBS Physics2001
Member, Regulatory Affairs Professionals Society® (RAPS)
Member, American Health Lawyers Association, 2011-present
- Speaker, FDA Regulation of LDTs, June 26, 2024
- Speaker, HIPAA for Medical Device Companies, January 17, 2024
- Moderator, "Minimizing Sales and Marketing Compliance Risks: Developing Compliant Sales Models and Value-added Services," The MedTech Conference, October 10, 2023
- Moderator, "Recent Enforcement Trends and Key Compliance Concerns to Consider in Preparing for an Investment, Offering, or Acquisition," The Medtech Conference, October 24, 2022
- Speaker, "Legal Developments Impacting Dialysis Providers," 2021 Dialysis Industry Legal Updates, Renal Healthcare Association, Webinar, November 3, 2021
- Speaker, Discounts Rebates Value-Based Pricing Models Medical Device Pharmaceutical Companies, December 8, 2020
- Speaker, Key Compliance Concerns for Medical Device Manufacturers in the Wake of COVID-19, September 15, 2020
- Moderator, "Current Fraud & Abuse Enforcement Issues," 10th Annual Pharmaceutical and Medical Device Conference, November 15, 2018
- Speaker, "Legal Perspectives," 3rd Annual Life Science Compliance Training Conference, Q1 Productions, June 7, 2018
- Moderator, "Current Fraud and Abuse Enforcement Issues," 16th Annual Business and Legal Issues in Dialysis and Nephrology Symposium, May 17, 2018
- Moderator, "Issues & Trends in Medical Device and Life Sciences Investments," 15th Annual Healthcare and Life Sciences Private Equity and Finance Conference, February 22, 2018
- Co-host and Moderator, "HCP Relationships and Current Enforcement Issues," 9th Annual Pharmaceutical and Medical Device Conference, Chicago, IL, November 16, 2017
- Moderator, "Current Fraud and Abuse Enforcement Issues Faced by Providers," 15th Annual Business and Legal Issues in Dialysis and Nephrology Symposium, May 18, 2017
- Moderator, "HCP Relationships and Current Enforcement Issues," 8th Annual Pharmaceutical and Medical Device Conference, November 10, 2016
- Moderator, "Staying Ahead of the Government: Self-Regulation Strategies for Ensuring Fraud and Abuse Compliance," 14th Annual Business and Legal Issues in Dialysis and Nephrology Symposium, May 19, 2016
- Panelist, "Uncovering Anti-Kickback Pitfalls in Your Medical Device Contracts, Training and Education in a Changing Regulatory and Enforcement Climate," American Conference Institute’s 16th Advanced Forum on Fraud and Abuse in the Sales & Marketing of Medical Devices, American Conference Institute, March 8, 2016
- Moderator, "Executive Roundtable - Medical Device Industry Update," 7th Annual Medical Device and Life Sciences Conference, November 19, 2015
- Speaker, "Operating Profitably in a Climate of Scrutiny: Why Compliance is Good Business and How to Achieve it," 13th Annual Business and Legal Issues in Dialysis and Nephrology Symposium, April 14, 2015
- Moderator, "HCP Relationships, Open Payments and Current Enforcement Issues," 6th Annual Medical Device and Life Sciences Conference, November 18, 2014
- Speaker, "Structuring Your Medical Practice for Tomorrow While Effectively Addressing Today's Issues," 12th Annual Business and Legal Issues in Dialysis and Nephrology Symposium, May 15, 2014
- Illinois
Named to “Illinois Rising Stars,” Healthcare, Super Lawyers, Thomson Reuters, 2020
- Author, CMS Issues 2025 End-Stage Renal Disease Prospective Payment System Final Rule, McGuireWoods Legal Alert, December 2, 2024
- Author, Key Takeaways From McGuireWoods’ Webinar on HIPAA and Cybersecurity for Medical Device Companies, McGuireWoods Legal Alert, January 26, 2024
- Host, Medical Device Legal News: Episode 19, January 5, 2024
- Author, Life Sciences Companies Face Continuing Compliance Challenges in Developing Value-Based and Value-Added Models, McGuireWoods Legal Alert, December 28, 2023
- Author, FDA Issues Draft Guidance on Providing Health Care Providers With Scientific Information on Unapproved Uses of Approved/Cleared Medical Products, McGuireWoods Legal Alert, December 21, 2023
- Host, Medical Device Legal News: Episode 18, December 6, 2023
- Host, Medical Device Legal News: Episode 17, November 15, 2023
- Author, CMS Issues End-Stage Renal Disease Prospective Payment System Final Rule for 2024, McGuireWoods Legal Alert, November 6, 2023
- Author, FDA Establishes and Solicits Nominations for Digital Health Advisory Committee, McGuireWoods Legal Alert, November 3, 2023
- Host, Medical Device Legal News: Episode 16, October 25, 2023
- Host, Medical Device Legal News: Episode 15, October 7, 2023
- Host, Medical Device Legal News: Episode 14, September 19, 2023
- Host, Medical Device Legal News: Episode 13, August 22, 2023
- Author, Mobile App Company Resolves DOJ and FTC Allegations of Health Breach Notification Rule and FTC Act Privacy Violations, McGuireWoods Legal Alert, August 11, 2023
- Host, Medical Device Legal News: Episode 12, August 8, 2023
- Host, Medical Device Legal News: Episode 11, July 18, 2023
- Host, Medical Device Legal News: Episode 10, June 27, 2023
- Host, Medical Device Legal News: Episode 9, June 13, 2023
- Host, Medical Device Legal News: Episode 8, June 6, 2023
- Author, New York Pharmacy Owners Indicted for Alleged Healthcare Fraud Scheme, McGuireWoods Legal Alert, May 31, 2023
- Host, Medical Device Legal News: Episode 7, May 23, 2023
- Host, Medical Device Legal News: Episode 6, May 16, 2023
- Host, Medical Device Legal News: Episode 5, May 9, 2023
- Host, Medical Device Legal News: Episode 4, May 2, 2023
- Author, End of COVID-19 Emergency: Legal Implications for Healthcare Providers, McGuireWoods Legal Alert, May 1, 2023
- Host, Medical Device Legal News: Episode 3, April 18, 2023
- Host, Medical Device Legal News: Episode 2, April 12, 2023
- Host, Medical Device Legal News: Episode 1, April 4, 2023
- Author, Ophthalmic Distributor May Face Up to $848M in Penalties for Kickbacks, False Claims Act Violations, The FCA Insider, March 21, 2023
- Author, CMS Issues ESRD Prospective Payment System Final Rule for 2023, McGuireWoods Legal Alert, November 7, 2022
- Author, Pharmaceutical Manufacturer Agrees to $900M False Claims Act Settlement to Resolve Kickback Claims, Subject to Inquiry, August 10, 2022
- Author, CMMI Releases Request for Applications for Kidney Care Choices Model, Performance Year 2023, McGuireWoods Legal Alert, March 1, 2022
- Author, OIG Issues Special Fraud Alert That Challenges Industry Norms Regarding Speakers Programs, McGuireWoods Legal Alert, November 20, 2020
- Author, CMS Grants ESRD Facilities More Flexibility, Waives Certain Conditions for Coverage During COVID-19, McGuireWoods Legal Alert, April 3, 2020
- Author, CMS Announces Enforcement Discretion for Late Open Payments Reporting Due to COVID-19, McGuireWoods Legal Alert, March 31, 2020
- Author, 10 Key Points CMS Guidance Dialysis Facilities COVID-19, McGuireWoods Legal Alert, March 27, 2020
- Author, FDA Waives Premarket Notification Requirements for Ventilator Manufacturers, Solicits Manufacturers for Ventilator Support Devices Under Emergency Use Authorizations, McGuireWoods Legal Alert, March 27, 2020
- Author, CMS Proposes Revising Physician Payments Sunshine Act Reporting Requirements, McGuireWoods Legal Alert, September 18, 2019
- Author, AdvaMed Revises Code of Ethics on Interactions with Health Care Professionals, McGuireWoods Legal Alert, August 7, 2019
- Co-author, "Navigating the Newly Adopted Local Transportation Safe Harbor to the Federal Anti-Kickback Statute," Bender's Health Care Law Monthly, May 2017
- Author, CMS Adopts ESRD PPS and QIP Final Rule for Dialysis Services, McGuireWoods Legal Alert, November 11, 2015
- Co-author, "Key Legal Issues for Nephrology Practices: Structure and Governance," Renal Physicians Association News, May 2014
- Author, Drugs Made by Compounders That Operate in Violation of the Food, Drug, and Cosmetic Act Create Recoupment Risk, McGuireWoods Legal Alert, February 10, 2014
- Author, DME Suppliers Must Adopt Procedures to Ensure Compliance with the ACA’s Face-to-Face Requirement, McGuireWoods Legal Alert, January 31, 2014
- Author, Five Key Points Regarding the Assignment of Receivables in Healthcare Transactions, McGuireWoods Legal Alert, October 12, 2012
- Author, Noncompliant Leases, McGuireWoods Legal Alert, September 20, 2012